Analystreport

CymaBay Therapeutics, Inc. (NASDAQ: CBAY) is now covered by analysts at BTIG Research. They set a "buy" rating and a $15.00 price target on the stock.

CymaBay Therapeutics Inc.  (CBAY) 
Last cymabay therapeutics inc. earnings: 3/12 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cymabay.com